Huajin Investment News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Atom Bioscience Raises $83M in a D-Round Financing to Support Global Pivotal Clinical Trials of ABP-671, a New Treatment for Chronic Gout
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Startup Funding: January 2023
semiengineering.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from semiengineering.com Daily Mail and Mail on Sunday newspapers.
General Atlantic, IDG lead $100m fourth round for Chinese biotech firm Biotheus
Source: National Cancer Institute/Unsplash
March 4, 2021
Biotheus, a Chinese biotech firm focusing on the treatment of malignant tumours and autoimmune diseases, has secured over $100 million in its fourth funding round co-led by growth equity investor General Atlantic and Beijing-based investment firm IDG Capital.
New investors in the round include Chinese private equity (PE) firm Kunlun Capital, CITIC’s asset management firm CPE, and Shenzhen-based PE Cowin Capital, Biotheus said in a statement on Wednesday.
Returning investors such as healthcare-focused investment companies HighLight Capital and Shiyu Capital, Chinese fund manager New Alliance Capital, and Huajin Investment participated in the deal.